Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

InflaRx N.V. - Common Stock (NQ:IFRX)

1.270 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.270
Bid (Size) 1.280 (100)
Ask (Size) 1.300 (100)
Prev. Close 1.270
Today's Range 1.270 - 1.270
52wk Range 0.7113 - 2.815
Shares Outstanding 44,203,763
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biogen's Immunology Pipeline Has Long-Term Potential: Analyst
Biogen gains exclusive rights to Vanqua's oral C5aR1 antagonist, boosting its immunology pipeline with potential across multiple immune diseases. 
Via Benzinga
Top 4 Biotech Stocks Set For A Breakout: Momentum Scores Surge
Several biotech stocks are showing renewed strength over the past week, with their Momentum scores soaring in Benzinga's Edge Stock Rankings. 
Via Benzinga

Performance

YTD
-49.2%
-49.2%
1 Month
-15.9%
-15.9%
3 Month
+44.3%
+44.3%
6 Month
-21.1%
-21.1%
1 Year
-18.6%
-18.6%

More News

Read More
Top movers analysis one hour before the close of the markets on 2025-08-29: top gainers and losers in today's session.
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Earnings Scheduled For August 7, 2025
Via Benzinga
Earnings Scheduled For May 7, 2025
Via Benzinga
Preview: InflaRx's Earnings
Via Benzinga
Top movers in Friday's session
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Via Chartmill
Top movers analysis in the middle of the day on 2025-05-28: top gainers and losers in today's session.
Via Chartmill
Crude Oil Gains 2%; Macy's Lowers Earnings Forecast
Via Benzinga
InflaRx Ends Lead Asset Development After Failed Study For Rare And Painful Skin Disease
Via Benzinga
These stocks are gapping in today's session
Via Chartmill
US Stocks Gain; Abercrombie & Fitch Posts Upbeat Earnings
Via Benzinga
Get insights into the top gainers and losers of Wednesday's pre-market session.
Via Chartmill
Why Box Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
This Centessa Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday
Via Benzinga
Carnival To Rally Over 50%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Earnings Scheduled For March 20, 2025
Via Benzinga
Infinitum: Pioneering Quantum-Proof Blockchain Solutions to Transform Finance
Via ACCESS Newswire
Friday's session: top gainers and losers
Via Chartmill
What's going on in today's session
Via Chartmill
Friday's session: gap up and gap down stocks
Via Chartmill
Top movers in Friday's pre-market session
Via Chartmill

Frequently Asked Questions

Is InflaRx N.V. - Common Stock publicly traded?
Yes, InflaRx N.V. - Common Stock is publicly traded.
What exchange does InflaRx N.V. - Common Stock trade on?
InflaRx N.V. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for InflaRx N.V. - Common Stock?
The ticker symbol for InflaRx N.V. - Common Stock is IFRX on the Nasdaq Stock Market
What is the current price of InflaRx N.V. - Common Stock?
The current price of InflaRx N.V. - Common Stock is 1.270
When was InflaRx N.V. - Common Stock last traded?
The last trade of InflaRx N.V. - Common Stock was at 11/04/25 04:00 PM ET
What is the market capitalization of InflaRx N.V. - Common Stock?
The market capitalization of InflaRx N.V. - Common Stock is 56.14M
How many shares of InflaRx N.V. - Common Stock are outstanding?
InflaRx N.V. - Common Stock has 56M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.